| Malignancy |  | ||
---|---|---|---|---|
Malignant (n = 145, 85.8%) | Benign (n = 24, 14.2%) | p | ||
Age (year) | median (min-max) | 61 (33–84) | 63 (39–76) | a0.472 |
Gender (n, %) | Male | 98 (89.9) | 11 (10.1) | b0.039* |
Female | 47 (78.3) | 13 (21.7) | ||
Side (n, %) | Right | 73 (86.9) | 11 (13.1) | b0.682 |
Left | 72 (84.7) | 13 (15.3) | ||
Size (cm) | median (min-max) | 8 (2–18) | 5 (3–11) | a0.223 |
Localization (n, %) | Lower Pole | 23 (88.5) | 3 (11.5) | b0.848 |
Middle Pole | 82 (84.5) | 15 (15.5) | ||
Upper Pole | 40 (87.0) | 6 (13.0) | ||
Smoking Status (n, %) | Exist | 105 (90.5) | 11 (9.5) | b0.009** |
None | 40 (75.5) | 13 (24.5) | ||
Diabetes Mellitus (n, %) | Exist | 57 (85.1%) | 10 (14.9%) | b0.827 |
None | 88 (86.3%) | 14 (13.7%) | ||
Hypertension (n, %) | Exist | 95 (90.5%) | 10 (9.5%) | b0.026* |
None | 50 (78.1%) | 14 (21.9%) | ||
Body Mass Index (kg/m2) | mean ± SD | 29.30 ± 4.36 | 27.16 ± 3.27 | c0.023* |
Triglyceride Value [mg/dl] | median (min-max) | 156 (68–1019) | 164 (100–226) | a0.383 |
HDL-Cholesterole Value [mg/dl] | mean ± SD | 39.64 ± 11.53 | 50.04 ± 10.59 | c0.001** |
Plasma Atherogenic Index Value | median (min-max) | 0.63 (0.34–1.58) | 0.62 (0.39–0.76 | a0.003** |